Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sima Rafati

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
Frontiers in Microbiology|April 20, 2016
Post-Genomics and Vaccine Improvement for LeishmaniaNegar Seyed, Tahereh Taheri, Sima Rafati
Human Vaccines|August 18, 2009
Different spectra of therapeutic vaccine development against HPV infectionsAzam Bolhassani, Elham Mohit, Sima Rafati
Molecular Cancer|January 8, 2011
Improvement of different vaccine delivery systems for cancer therapyAzam Bolhassani, Shima Safaiyan, Sima Rafati
Vaccine|December 6, 2005
Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasisSima Rafati, Farnaz Zahedifard, Fereshteh Nazgouee
Expert Review of Vaccines|February 25, 2016
Delivery systems for Leishmania vaccine developmentElham Gholami, Farnaz Zahedifard, Sima Rafati
Cytokine|October 31, 2020
Cytokine saga in visceral leishmaniasisRenuka Bhor, Sima Rafati, Kalpana Pai
Cellular Immunology|October 13, 2016
Mammalian host defense peptides and their implication on combating Leishmania infectionZahra Abdossamadi, Negar Seyed, Sima Rafati
Expert Review of Proteomics|September 4, 2020
Transcriptomic profiling in Cutaneous Leishmaniasis patientsNasrin Masoudzadeh, Amir Mizbani, Sima Rafati
Vaccine|February 17, 2006
Comparison of potential protection induced by three vaccination strategies (DNA/DNA, Protein/Protein and DNA/Protein) against Leishmania major infection using Signal Peptidase type I in BALB/c miceSima Rafati, Fatemeh Ghaemimanesh, Farnaz Zahedifard
Frontiers in Immunology|April 19, 2014
Live vaccination tactics: possible approaches for controlling visceral leishmaniasisNoushin Saljoughian, Tahareh Taheri, Sima Rafati
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
Frontiers in Microbiology|April 20, 2016
Post-Genomics and Vaccine Improvement for LeishmaniaNegar Seyed, Tahereh Taheri, Sima Rafati
Human Vaccines|August 18, 2009
Different spectra of therapeutic vaccine development against HPV infectionsAzam Bolhassani, Elham Mohit, Sima Rafati
Molecular Cancer|January 8, 2011
Improvement of different vaccine delivery systems for cancer therapyAzam Bolhassani, Shima Safaiyan, Sima Rafati
Vaccine|December 6, 2005
Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasisSima Rafati, Farnaz Zahedifard, Fereshteh Nazgouee
Expert Review of Vaccines|February 25, 2016
Delivery systems for Leishmania vaccine developmentElham Gholami, Farnaz Zahedifard, Sima Rafati
Cytokine|October 31, 2020
Cytokine saga in visceral leishmaniasisRenuka Bhor, Sima Rafati, Kalpana Pai
Cellular Immunology|October 13, 2016
Mammalian host defense peptides and their implication on combating Leishmania infectionZahra Abdossamadi, Negar Seyed, Sima Rafati
Expert Review of Proteomics|September 4, 2020
Transcriptomic profiling in Cutaneous Leishmaniasis patientsNasrin Masoudzadeh, Amir Mizbani, Sima Rafati
Vaccine|February 17, 2006
Comparison of potential protection induced by three vaccination strategies (DNA/DNA, Protein/Protein and DNA/Protein) against Leishmania major infection using Signal Peptidase type I in BALB/c miceSima Rafati, Fatemeh Ghaemimanesh, Farnaz Zahedifard
Frontiers in Immunology|April 19, 2014
Live vaccination tactics: possible approaches for controlling visceral leishmaniasisNoushin Saljoughian, Tahareh Taheri, Sima Rafati
Pageof 14